Cardiol Therapeutics
Stock Forecast, Prediction & Price Target
Cardiol Therapeutics Financial Estimates
Cardiol Therapeutics Revenue Estimates
Cardiol Therapeutics EBITDA Estimates
Cardiol Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CA$78.76K N/A | CA$0 -100% | CA$0 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | Avg: CA$3.67M Low: CA$3.67M High: CA$3.67M avg. 0% | Avg: CA$67.32M Low: CA$67.32M High: CA$67.32M avg. 1731.92% | Avg: CA$179.79M Low: CA$179.79M High: CA$179.79M avg. 167.05% |
Net Income
% change YoY
| CA$-24.72M N/A | CA$-11.52M 53.39% | CA$-28.12M -144.12% | Avg: CA$-33.96M Low: CA$-31.58M High: CA$-16.76M avg. -20.74% | Avg: CA$-36M Low: CA$-34.16M High: CA$-19.33M avg. -5.99% | Avg: CA$4.20M Low: CA$4.20M High: CA$4.20M avg. 111.69% | Avg: CA$54.21M Low: CA$54.21M High: CA$54.21M avg. 1187.89% |
EBITDA
% change YoY
| CA$-45.25M N/A | CA$-50.11M -10.75% | CA$-27.87M 44.37% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 100% | Avg: CA$2.20M Low: CA$2.20M High: CA$2.20M avg. 0% | Avg: CA$40.39M Low: CA$40.39M High: CA$40.39M avg. 1731.92% | Avg: CA$107.87M Low: CA$107.87M High: CA$107.87M avg. 167.05% |
EPS
% change YoY
| -$0.57 N/A | -$0.18 68.42% | -$0.44 -144.44% | Avg: -$0.42 Low: -$0.49 High: -$0.26 avg. 3.97% | Avg: -$0.42 Low: -$0.53 High: -$0.3 avg. 1.77% | Avg: $0.07 Low: $0.07 High: $0.07 avg. 115.73% | Avg: $0.84 Low: $0.84 High: $0.84 avg. 1187.89% |
Operating Expenses
% change YoY
| CA$38.74M N/A | CA$41.33M 6.69% | CA$29.53M -28.54% | Avg: CA$0 Low: CA$0 High: CA$0 avg. -100% | Avg: CA$263.05M Low: CA$263.05M High: CA$263.05M avg. 0% | Avg: CA$4.81B Low: CA$4.81B High: CA$4.81B avg. 1731.92% | Avg: CA$12.86B Low: CA$12.86B High: CA$12.86B avg. 167.05% |
FAQ
What is Cardiol Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 318.21% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -31.58M, average is -33.96M and high is -16.76M.
What is Cardiol Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 474.74% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Cardiol Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 327.34% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.49, average is -$0.42 and high is CA$-0.26.